Clinical Trial Update: Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

View source ↗

Summary

A clinical trial evaluating Yttrium-90 radioembolization as neoadjuvant therapy with immune marker profiling and dosimetry for potentially resectable colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Fernando Gómez Muñoz | Conditions: Colorectal Liver Metastases (CRCLM), Unresectable Colorectal Liver Metastases | Status: NOT_YET_RECRUITING